Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Neurology(R) Neuroimmunology & Neuroinflammation|May 6, 2022
Longitudinal T-Cell Responses After a Third SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis on Ocrelizumab or FingolimodVirginia Palomares Cabeza, Laura Y L Kummer, Luuk Wieske, et al.
The Lancet. Rheumatology|August 16, 2021
Antibody development after COVID-19 vaccination in patients with autoimmune diseases in the Netherlands: a substudy of data from two prospective cohort studiesLaura Boekel, Maurice Steenhuis, Femke Hooijberg, et al.
Iscience|September 6, 2023
Comparative analysis of spike-specific IgG Fc glycoprofiles elicited by adenoviral, mRNA, and protein-based SARS-CoV-2 vaccinesJulie Van Coillie, Tamas Pongracz, Tonći Šuštić, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 9, 2021
SARS-CoV-2 neutralising antibody testing in Europe: towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial dataDung Nguyen, Peter Simmonds, Maurice Steenhuis, et al.
European Journal of Immunology|January 8, 2026
SARS-CoV-2 mRNA Vaccination Leads to Transient Humoral and B Cell Bystander Responses in AdultsLisan H Kuijper, Laura Y L Kummer, Laura Fernandez Blanco, et al.
RMD Open|August 4, 2025
TNF inhibitors affect the induction and maintenance of spike-specific B-cell responses after mRNA vaccinationLaura Yl Kummer, Lisan H Kuijper, Laura Fernández Blanco, et al.
Ebiomedicine|February 26, 2025
Evolution of SARS-CoV-2 antibody repertoire after successive mRNA vaccinations under immunosuppressive treatmentJim B D Keijser, Eileen W Stalman, Luuk Wieske, et al.
Elife|July 15, 2022
Immune dynamics in SARS-CoV-2 experienced immunosuppressed rheumatoid arthritis or multiple sclerosis patients vaccinated with mRNA-1273Niels J M Verstegen, Ruth R Hagen, Jet van den Dijssel, et al.
Allergy|March 5, 2024
Suppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after mRNA vaccinationAnika M Valk, Jim B D Keijser, Koos P J van Dam, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 28, 2024
T cell activation markers CD38 and HLA-DR indicative of non-seroconversion in anti-CD20-treated patients with multiple sclerosis following SARS-CoV-2 mRNA vaccinationNiels J M Verstegen, Ruth R Hagen, Christine Kreher, et al.
Pageof 6